51.90 0.00 (0.00%)
After hours: 4:31PM EDT
|Bid||50.20 x 2200|
|Ask||52.54 x 900|
|Day's Range||50.35 - 52.14|
|52 Week Range||48.14 - 75.75|
|PE Ratio (TTM)||64.07|
|Earnings Date||Nov 5, 2018 - Nov 9, 2018|
|Forward Dividend & Yield||1.91 (3.75%)|
|1y Target Est||54.93|
Now it is quietly building a side business: getting paid to help drug companies dispense a new generation of high-priced drugs. Express Scripts is in talks with biotechnology companies Biomarin Pharmaceutical Inc (BMRN.O), Spark Therapeutics Inc (ONCE.O) and Bluebird Bio Inc (BLUE.O) to have its specialty pharmaceutical business exclusively distribute their new haemophilia therapies when they are expected to become available in 2019 and 2020, Chief Medical Officer Steve Miller told Reuters in an interview.
NEW YORK, Aug. 14, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Automatic ...
DUBLIN, Ohio , Aug. 8, 2018 /PRNewswire/ -- The Cardinal Health (NYSE: CAH) board of directors today approved a quarterly dividend of $0.4763 per share. The dividend will be payable on October 15, 2018 to ...
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Consumer Services sector is rising.
Nearly 10 years into the bull market, it’s getting progressively more difficult to find value in stocks. There are still good deals to be found, but value investors face the ever-present danger of trying to “catch a falling knife” and being cut as the shares fall further. #-ad_banner-#Learning how to catch the temporary discounts while avoiding the stocks with farther to fall comes down to finding the companies with the financial flexibility and strength to survive.
MARKET PULSE Cardinal Health Inc. (CAH) shares rose 1.5% in heavy Monday morning trade after the company reported fourth-quarter profit and revenue beats. The company reported a loss of $1.2 billion, or a loss of $3.
Cardinal Health (CAH) witnesses strong Q4, owing to strong sales at Pharmaceutical and the Medical segments. It provides an impressive FY19 view.
Cardinal (CAH) delivered earnings and revenue surprises of 8.60% and 2.32%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Indra Nooyi will step down as CEO of the snack and beverage giant on October 3 after 12 years, replaced by President Ramon Laguarta. Berkshire Hathaway BRK.A – Berkshire reported quarterly profit of $4190.13 per "A" share , beating the consensus estimate of $3386.62, while revenue also topped estimates. Warren Buffett's firm saw profits jump 67 percent from a year earlier, helped in part by a rebound in Berkshire's insurance business.
On a per-share basis, the Dublin, Ohio-based company said it had a loss of $3.76. Earnings, adjusted for one-time gains and costs, were $1.01 per share. The results topped Wall Street expectations. The ...
U.S. drug distributor Cardinal Health Inc beat analyst estimates for adjusted fourth-quarter profit on Monday, supported by higher sales in its pharmaceutical and medical devices businesses. The company has been plagued with issues at its Cordis medical device unit, which it bought for $1.9 billion in 2015 from Johnson & Johnson. The company had missed quarterly profit expectations in May due to inventory and cost issues at the unit.
Cardinal Health Inc reported a fourth-quarter loss compared to a year-ago profit, as the U.S. drug distributor was hit by an asset-impairment charge of $1.35 billion. Net loss attributable to the company ...
- Fourth-quarter revenue increased 7 percent to $35 billion ; full-year revenue increased 5 percent to $137 billion - Full-year GAAP(1) operating earnings were $126 million and non-GAAP operating earnings ...
The Medical product market gains momentum owing to the recent two-year suspension of the controversial 2.3% Medical Device tax.
Ten Missouri counties and one city filed suit Wednesday against 49 companies, accusing them of worsening the opioid epidemic by misbranding drugs, among other things. The 274-page lawsuit, filed in St. Louis Circuit Court, seeks damages on behalf of the plaintiffs and their residents. The plaintiffs are Jefferson, Cape Girardeau, Christian, Crawford, Greene, Iron, Jasper, Stone, Taney, and Washington counties, and the city of Joplin.
On upbeat consumer sentiment and increased business investments, the dental supplies industry appears to be in the pink of health now.
NaviHealth CEO Clay Richards has a simple explanation for why 55 percent of the company was sold to a private equity firm last month — it’s time to grow.